Are you looking for recent Pharma Magazine information?
Check out the Top News in Pharma Magazine, Leading Magazine in the Pharma Industry, and most recent pharmaceutical news. Daily information updates related to the industrial sectors we work in are presented in the pharmaceutical industry's news area
Kamau Therapeutics a company in the clinicalstage of gene correction has recently emerged from stealth mode following a strategic deal with Graphite Bio
EnGeneIC an innovative biopharmaceutical company leading the field of armed antibody therapeutics for oncology has achieved a significant milestone with the FDA granting FastTrack designation for its pancreatic cancer therapeutic
BioGenCell a leader in the field of personalized cell therapy solutions is pleased to announce the commencement of its fifth Phase II clinical trial site in the United States at the University of Maryland Medical Center
Ten Therapeutics a biotechnology company has unveiled a collaboration with Boehringer Ingelheim for multitarget drug discovery The partnership aims to discover innovative therapeutic molecules to address diseases
Mendus AB a biopharmaceutical company specializing in immunotherapies for tumor recurrence has recently disclosed a partnership with the Australasian Leukaemia Lymphoma Group
Osteal Therapeutics has received Breakthrough Therapy Designation from the US Food and Drug Administration for VTX an investigational drug therapy targeting periprosthetic joint infection in the hip and knee
Merck KGaA Darmstadt Germany a leading science and technology company has recently unveiled a license agreement with Abbisko Therapeutics Co Ltd in Shanghai China for pimicotinib
Nona Biosciences a global leader in technology innovation and antibody discovery solutions recently announced a collaboration agreement with Lycia Therapeutics a company specializing in extracellular protein degradation
Bio Inc a biotechnology company in the clinical stage focused on developing precision oncology medicines has announced the initiation of treatment for the first patient with TEB a small molecule inhibitor designed
Phenomic AI Inc a biotech company dedicated to developing therapies for stromarich tumors using its scTx singlecell transcriptomics platform has established a strategic research collaboration with Astellas Pharma Inc
